Statements of Assets and Liabilities (Unaudited) - USD ($) $ in Thousands		Mar. 31, 2025	Dec. 31, 2024
Assets
Non-controlled, non-affiliated investments at fair value (amortized cost $51,352 and $0, respectively)		$ 51,324	$ 0	[1]
Cash and cash equivalents		67,546	32,280
Deferred offering costs		925	1,226
Deferred financing costs		1,535	578
Interest receivable		594	0
Dividend receivable		37	35
Total Assets		121,961	34,119
Liabilities
Debt		47,600	0	[2]
Due to affiliate		1,508	1,140
Interest payable		227	0
Management fee payable		42	0
Accrued expenses and other liabilities		246	588
Total Liabilities		49,623	1,728
Commitments and contingencies (Note 7)
Net Assets
Preferred Stock, $0.001 par value; 1,000,000 shares authorized; 515 and 515 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively; liquidation preference of $3,000 per share	[3]	0	0
Common Stock, $0.001 par value; 5,000,000,000 shares authorized; 2,857,196 and 1,242,991 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively		3	1
Distributable earnings (Accumulated losses)		(53)	0
Total Net Assets	[4]	72,338	32,391
Total Liabilities and Net Assets		$ 121,961	$ 34,119
Net Asset Value Per Share of Common Stock	[5],[6]	$ 24.78	$ 24.82
Common Stock [Member]
Net Assets
Additional paid-in capital		$ 70,843	$ 30,845
Preferred Stock [Member]
Net Assets
Additional paid-in capital		$ 1,545	$ 1,545

[1] As of December 31, 2024, the Company had not yet commenced investment operations.

[2] The Company did not have any outstanding debt as of December 31, 2024

[3] (1) The par amount of Preferred Stock at March 31, 2025 and December 31, 2024 is zero due to rounding.

[4] The par amounts of Preferred Stock are zero due to rounding.

[5] (2) Net asset value per share of Common Stock may not recalculate due to rounding.

[6] Financial highlights for the three months ended March 31, 2024 are not presented as this period was prior to August 30, 2024, the date on which the Company became subject to the reporting requirements under the 1934 Act.